LUCID DIAGNOSTICS INC (LUCD) Fundamental Analysis & Valuation

NASDAQ:LUCD • US54948X1090

Current stock price

1.35 USD
+0.07 (+5.47%)
At close:
1.3799 USD
+0.03 (+2.21%)
After Hours:

This LUCD fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. LUCD Profitability Analysis

1.1 Basic Checks

  • LUCD had negative earnings in the past year.
  • In the past year LUCD has reported a negative cash flow from operations.
  • LUCD had negative earnings in each of the past 5 years.
  • LUCD had a negative operating cash flow in each of the past 5 years.
LUCD Yearly Net Income VS EBIT VS OCF VS FCFLUCD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 -20M -40M -60M

1.2 Ratios

  • With a Return On Assets value of -174.48%, LUCD is not doing good in the industry: 88.83% of the companies in the same industry are doing better.
  • Looking at the Return On Equity, with a value of -645.29%, LUCD is doing worse than 88.83% of the companies in the same industry.
Industry RankSector Rank
ROA -174.48%
ROE -645.29%
ROIC N/A
ROA(3y)-180.08%
ROA(5y)-152.12%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LUCD Yearly ROA, ROE, ROICLUCD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 -10K -20K -30K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for LUCD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LUCD Yearly Profit, Operating, Gross MarginsLUCD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 -5K -10K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. LUCD Health Analysis

2.1 Basic Checks

  • LUCD does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for LUCD has been increased compared to 1 year ago.
  • Compared to 5 years ago, LUCD has more shares outstanding
  • The debt/assets ratio for LUCD has been reduced compared to a year ago.
LUCD Yearly Shares OutstandingLUCD Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
LUCD Yearly Total Debt VS Total AssetsLUCD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M

2.2 Solvency

  • Based on the Altman-Z score of -8.31, we must say that LUCD is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -8.31, LUCD is doing worse than 78.19% of the companies in the same industry.
  • A Debt/Equity ratio of 2.19 is on the high side and indicates that LUCD has dependencies on debt financing.
  • LUCD's Debt to Equity ratio of 2.19 is on the low side compared to the rest of the industry. LUCD is outperformed by 84.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.19
Debt/FCF N/A
Altman-Z -8.31
ROIC/WACCN/A
WACC8.53%
LUCD Yearly LT Debt VS Equity VS FCFLUCD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M -40M

2.3 Liquidity

  • LUCD has a Current Ratio of 1.31. This is a normal value and indicates that LUCD is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of LUCD (1.31) is worse than 84.57% of its industry peers.
  • LUCD has a Quick Ratio of 1.30. This is a normal value and indicates that LUCD is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Quick ratio value of 1.30, LUCD is not doing good in the industry: 67.55% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.31
Quick Ratio 1.3
LUCD Yearly Current Assets VS Current LiabilitesLUCD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. LUCD Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 24.53% over the past year.
  • Looking at the last year, LUCD shows a quite strong growth in Revenue. The Revenue has grown by 8.28% in the last year.
  • LUCD shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 131.36% yearly.
EPS 1Y (TTM)24.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%44.44%
Revenue 1Y (TTM)8.28%
Revenue growth 3Y131.36%
Revenue growth 5YN/A
Sales Q2Q%25.65%

3.2 Future

  • Based on estimates for the next years, LUCD will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.10% on average per year.
  • Based on estimates for the next years, LUCD will show a very strong growth in Revenue. The Revenue will grow by 89.51% on average per year.
EPS Next Y65.49%
EPS Next 2Y31.78%
EPS Next 3Y20.98%
EPS Next 5Y12.1%
Revenue Next Year128.76%
Revenue Next 2Y133.71%
Revenue Next 3Y84.62%
Revenue Next 5Y89.51%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
LUCD Yearly Revenue VS EstimatesLUCD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20M 40M 60M 80M 100M
LUCD Yearly EPS VS EstimatesLUCD Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 -0.5 -1 -1.5

More info and screens

Find the best growth stocksShow best growing peers

1

4. LUCD Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for LUCD. In the last year negative earnings were reported.
  • Also next year LUCD is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LUCD Price Earnings VS Forward Price EarningsLUCD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LUCD Per share dataLUCD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6

4.3 Compensation for Growth

  • A more expensive valuation may be justified as LUCD's earnings are expected to grow with 20.98% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y31.78%
EPS Next 3Y20.98%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. LUCD Dividend Analysis

5.1 Amount

  • LUCD does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

LUCD Fundamentals: All Metrics, Ratios and Statistics

LUCID DIAGNOSTICS INC

NASDAQ:LUCD (4/14/2026, 8:22:41 PM)

After market: 1.3799 +0.03 (+2.21%)

1.35

+0.07 (+5.47%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-25
Earnings (Next)05-12
Inst Owners18.96%
Inst Owner Change0%
Ins Owners6.72%
Ins Owner Change10.52%
Market Cap238.88M
Revenue(TTM)4.71M
Net Income(TTM)-70.57M
Analysts83.64
Price Target4.03 (198.52%)
Short Float %4.7%
Short Ratio8.39
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.5%
Min EPS beat(2)1.96%
Max EPS beat(2)11.04%
EPS beat(4)3
Avg EPS beat(4)-43.52%
Min EPS beat(4)-222.25%
Max EPS beat(4)35.18%
EPS beat(8)4
Avg EPS beat(8)-28.4%
EPS beat(12)6
Avg EPS beat(12)-18.94%
EPS beat(16)8
Avg EPS beat(16)-12.4%
Revenue beat(2)1
Avg Revenue beat(2)-2.03%
Min Revenue beat(2)-12.5%
Max Revenue beat(2)8.44%
Revenue beat(4)1
Avg Revenue beat(4)-10.25%
Min Revenue beat(4)-36.75%
Max Revenue beat(4)8.44%
Revenue beat(8)2
Avg Revenue beat(8)-10.74%
Revenue beat(12)3
Avg Revenue beat(12)-5.35%
Revenue beat(16)3
Avg Revenue beat(16)-22.72%
PT rev (1m)4.17%
PT rev (3m)4.17%
EPS NQ rev (1m)14.78%
EPS NQ rev (3m)14.78%
EPS NY rev (1m)20.58%
EPS NY rev (3m)20.11%
Revenue NQ rev (1m)-10.33%
Revenue NQ rev (3m)-10.33%
Revenue NY rev (1m)-10.99%
Revenue NY rev (3m)-10.99%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 50.76
P/FCF N/A
P/OCF N/A
P/B 21.84
P/tB 22.49
EV/EBITDA N/A
EPS(TTM)-0.8
EYN/A
EPS(NY)-0.28
Fwd EYN/A
FCF(TTM)-0.26
FCFYN/A
OCF(TTM)-0.26
OCFYN/A
SpS0.03
BVpS0.06
TBVpS0.06
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -174.48%
ROE -645.29%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-180.08%
ROA(5y)-152.12%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 2.19
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 22.59%
Cap/Sales 4.19%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.31
Quick Ratio 1.3
Altman-Z -8.31
F-Score4
WACC8.53%
ROIC/WACCN/A
Cap/Depr(3y)28.93%
Cap/Depr(5y)N/A
Cap/Sales(3y)9.38%
Cap/Sales(5y)87.93%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)24.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%44.44%
EPS Next Y65.49%
EPS Next 2Y31.78%
EPS Next 3Y20.98%
EPS Next 5Y12.1%
Revenue 1Y (TTM)8.28%
Revenue growth 3Y131.36%
Revenue growth 5YN/A
Sales Q2Q%25.65%
Revenue Next Year128.76%
Revenue Next 2Y133.71%
Revenue Next 3Y84.62%
Revenue Next 5Y89.51%
EBIT growth 1Y-7.79%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year6.65%
EBIT Next 3Y3.6%
EBIT Next 5Y8.63%
FCF growth 1Y-4.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-5.31%
OCF growth 3YN/A
OCF growth 5YN/A

LUCID DIAGNOSTICS INC / LUCD Fundamental Analysis FAQ

What is the fundamental rating for LUCD stock?

ChartMill assigns a fundamental rating of 2 / 10 to LUCD.


Can you provide the valuation status for LUCID DIAGNOSTICS INC?

ChartMill assigns a valuation rating of 1 / 10 to LUCID DIAGNOSTICS INC (LUCD). This can be considered as Overvalued.


How profitable is LUCID DIAGNOSTICS INC (LUCD) stock?

LUCID DIAGNOSTICS INC (LUCD) has a profitability rating of 0 / 10.


Can you provide the financial health for LUCD stock?

The financial health rating of LUCID DIAGNOSTICS INC (LUCD) is 1 / 10.